Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
88.08%
-
Total 13F principal
-
$403,156,285
-
Principal change
-
-$14,054,279
-
Total reported market value
-
$355,394,283
-
Number of holders
-
56
-
Value change
-
-$12,627,997
-
Number of buys
-
16
-
Number of sells
-
28
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2018
As of 31 Mar 2018,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
56 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$403,156,285
in principal (par value) of the bond.
The largest 10 bondholders included
PRUDENTIAL PLC, Allianz Asset Management GmbH, CAPSTONE INVESTMENT ADVISORS, LLC, WELLS FARGO & COMPANY/MN, Southpaw Asset Management LP, OAKTREE CAPITAL MANAGEMENT LP, INCOME RESEARCH & MANAGEMENT, AXA, Invesco Ltd., and ADVENT CAPITAL MANAGEMENT /DE/.
This page lists
56
institutional bondholders reporting positions
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.